AZYO
Income statement / Annual
Last year (2022), Aziyo Biologics, Inc.'s total revenue was $49.19 M,
an increase of 3.79% from the previous year.
In 2022, Aziyo Biologics, Inc.'s net income was -$32.90 M.
See Aziyo Biologics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$49.19 M
|
$47.39 M
|
$42.68 M
|
$42.90 M
|
$39.04 M
|
| Cost of Revenue |
$29.97 M |
$28.37 M |
$22.12 M |
$23.13 M |
$23.09 M |
| Gross Profit |
$19.22 M |
$19.02 M |
$20.56 M |
$19.77 M |
$15.95 M |
| Gross Profit Ratio |
0.39 |
0.4 |
0.48 |
0.46 |
0.41 |
| Research and Development
Expenses |
$8.94 M
|
$9.27 M
|
$4.08 M
|
$2.40 M
|
$2.48 M
|
| General & Administrative
Expenses |
$16.63 M
|
$13.96 M
|
$13.23 M
|
$9.62 M
|
$8.52 M
|
| Selling & Marketing
Expenses |
$20.20 M
|
$18.83 M
|
$16.85 M
|
$16.16 M
|
$13.17 M
|
| Selling, General &
Administrative Expenses |
$36.82 M
|
$32.79 M
|
$30.08 M
|
$25.78 M
|
$21.69 M
|
| Other Expenses |
$4.16 M |
$3.58 M |
-$2.57 M |
$1.88 M |
$2.20 M |
| Operating Expenses |
$45.76 M |
$42.05 M |
$34.16 M |
$28.18 M |
$24.17 M |
| Cost And Expenses |
$75.73 M |
$70.42 M |
$56.28 M |
$51.31 M |
$47.26 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$5.28 M |
$5.32 M |
$5.63 M |
$5.38 M |
$5.52 M |
| Depreciation &
Amortization |
$4.16 M
|
$3.58 M
|
-$2.57 M
|
$5.74 M
|
$3.82 M
|
| EBITDA |
-$22.38 M
|
-$19.45 M
|
-$16.17 M
|
-$2.67 M
|
-$2.20 M
|
| EBITDA Ratio |
-0.46 |
-0.41 |
-0.38 |
-0.06 |
-0.06 |
| Operating Income Ratio
|
-0.54
|
-0.49
|
-0.32
|
-0.2
|
-0.21
|
| Total Other
Income/Expenses Net |
-$1.12 M
|
-$1.75 M
|
-$8.20 M
|
-$3.50 M
|
-$3.32 M
|
| Income Before Tax |
-$32.86 M |
-$24.78 M |
-$21.80 M |
-$11.91 M |
-$11.54 M |
| Income Before Tax Ratio
|
-0.67
|
-0.52
|
-0.51
|
-0.28
|
-0.3
|
| Income Tax Expense |
$34,000.00 |
$55,000.00 |
$26,000.00 |
$30,000.00 |
$26,000.00 |
| Net Income |
-$32.90 M |
-$24.83 M |
-$21.83 M |
-$11.94 M |
-$11.57 M |
| Net Income Ratio |
-0.67 |
-0.52 |
-0.51 |
-0.28 |
-0.3 |
| EPS |
-2.38 |
-2.38 |
-7.65 |
-1.82 |
-1.83 |
| EPS Diluted |
-2.38 |
-2.38 |
-7.65 |
-1.82 |
-1.83 |
| Weighted Average Shares
Out |
$13.83 M
|
$10.44 M
|
$2.85 M
|
$6.58 M
|
$6.31 M
|
| Weighted Average Shares
Out Diluted |
$13.83 M
|
$10.44 M
|
$2.85 M
|
$6.58 M
|
$6.31 M
|
| Link |
|
|
|
|
|
